Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012
Dispatch

Streptococcus pneumoniae Serotype 15A in Psychiatric Unit, Rhode Island, USA, 2010–2011

Katherine Fleming-DutraComments to Author , Chukwuma Mbaeyi, Ruth Link-Gelles, Nicole Alexander, Alice Guh, Elizabeth Forbes, Bernard Beall, Jonas M. Winchell, Maria da Gloria Carvalho, Fabiana Pimenta, Maja Kodani, Cindy Vanner, Hilary Stevens, Diane Brady, Mardea Caulcrick-Grimes, Utpala Bandy, and Matthew R. Moore
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Fleming-Dutra, C. Mbaeyi, R. Link-Gelles, A. Guh, B. Beall, J.M. Winchell, M.G. Carvalho, F. Pimenta, M. Kodani, H. Stevens, M.R. Moore); Rhode Island Department of Health, Providence, Rhode Island, USA (N. Alexander, C. Vanner, D. Brady, M. Caulcrick-Grimes, U. Bandy); Brown University–affiliated Hospitals, Providence (N. Alexander); Brown University, Providence (E. Forbes)

Main Article

Table 1

Characteristics of 20 psychiatric unit patients during Streptococcus pneumoniae serotype 15A outbreak, Rhode Island, USA, December 25, 2010–January 31, 2011

Characteristic No. (%) patients
Male sex 14 (70.0)
Median age, y (range) 13 (4–24)
Race

White

 16 (80.0)

Black

 4 (20.0)

Other/unknown

 0
Underlying medical conditions

Asthma*

 6 (30.0)

Chronic heart disease

 2 (10.0)

Other risk factors for pneumococcal infection†

 0
Median length of stay, days on Unit 1 as of January 30, 2011 (range) 71 (1–706)
Receiving systemic antimicrobial drugs during January for illness unrelated to outbreak 1 (5.0)
No. patients on Unit 1 as of January 30, 2011

Current in-patient

 15 (75.0)

Day program patient‡

 1 (20.0)

Discharged (since December 25, 2010)

 4 (5.0)

*None were treated with systemic steroids (i.e., none had an indication for vaccine) (3,4).
†Includes chronic lung disease (other than asthma), diabetes mellitus, cerebrospinal fluid leaks, cochlear implant, systemic steroid use, sickle cell disease, congenital or acquired asplenia, HIV infection, chronic renal failure, nephritic syndrome or kidney disease with dialysis, bone-marrow or organ transplant, diseases associated with treatment with immunosuppressive drugs or radiation therapy, including malignant neoplasms, leukemia, lymphoma, and Hodgkin disease (3,4).
‡Day program patients were treated in Unit 1 during the day and returned home to stay overnight with their families.

Main Article

References
  1. Huang  SS, Johnson  KM, Ray  GT, Wroe  P, Lieu  TA, Moore  MR, Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011;29:3398–412. DOIPubMedGoogle Scholar
  2. Basarab  M, Ihekweazu  C, George  R, Pebody  R. Effective management in clusters of pneumococcal disease: a systematic review. Lancet Infect Dis. 2011;11:119–30. DOIPubMedGoogle Scholar
  3. Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102–6.PubMedGoogle Scholar
  4. Nuorti  JP, Whitney  CG. Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-11):1–18.PubMedGoogle Scholar
  5. O’Brien  KL, Bronsdon  MA, Dagan  R, Yagupsky  P, Janco  J, Elliott  J, Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol. 2001;39:1021–4. DOIPubMedGoogle Scholar
  6. da Gloria Carvalho  M, Pimenta  FC, Jackson  D, Roundtree  A, Ahmad  Y, Millar  EV, Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol. 2010;48:1611–8. DOIPubMedGoogle Scholar
  7. Pai  R, Gertz  RE, Beall  B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124–31. DOIPubMedGoogle Scholar
  8. Centers for Disease Control and Prevention. PCR deduction of pneumococcal serotypes [cited 2011 Jan 29]. http://www.cdc.gov/ncidod/biotech/strep/PCR.htm
  9. Multi locus sequence typing. Streptococcus pneumoniae [cited 2011 Jan 29]. http://spneumoniae.mlst.net/
  10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first information supplement. Wayne (PA): The Institute; 2011.
  11. Kodani  M, Yang  G, Conklin  L, Travis  T, Whitney  C, Anderson  L, Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol. 2011;49:2175–82. DOIPubMedGoogle Scholar
  12. Peltola  VT, McCullers  JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(Suppl):S87–97. DOIPubMedGoogle Scholar
  13. Sá-Leão  R, Nunes  S, Brito-Avo  A, Frazao  N, Simoes  AS, Crisostomo  MI, Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect. 2009;15:1002–7. DOIPubMedGoogle Scholar
  14. Huang  SS, Hinrichsen  VL, Stevenson  AE, Rifas-Shiman  SL, Kleinman  K, Pelton  SI, Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1–11. DOIPubMedGoogle Scholar
  15. Gertz  RE Jr, Li  Z, Pimenta  FC, Jackson  D, Juni  BA, Lynfield  R, Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis. 2010;201:770–5. DOIPubMedGoogle Scholar

Main Article

Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external